Progress in functionalization of magnetic nanoparticles for applications in biomedicine

Journal of Physics D: Applied Physics

Volumn 42, Issue 22, 2009, Pages

  Berry, Catherine C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOAPPLICATIONS; CELL LABELLING; CELLULAR LEVELS; FUNCTIONALIZATIONS; MAGNETIC NANOPARTICLES; NANOMETRES; RESEARCH FIELDS;

MAGNETIC PROPERTIES;

NANOPARTICLES;

EID: 70450207654     PISSN: 00223727     EISSN: 13616463     Source Type: Journal    
DOI: 10.1088/0022-3727/42/22/224003     Document Type: Article

References (93)

1. Bulte J W M et al 2001 Nature Biotechnol. 19 1141-7
2. Berry C C, Wells S, Charles S and Curtis A S G 2003 Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro Biomaterials 24 4551-7
3. Berry C C, Wells S, Charles S, Atchinson G and Curtis A S G 2004 Cell response to dextran derivatised iron oxide nanoparticles Biomaterials 25 5405-13
4. Berry C C, Charles S, Wells S, Dalby M J and Curtis A S G 2004b The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture Int. J. Pharmaceutics 269 211-25
5. Soenan S J H, Vercauteren D, Braeckmans K, Noppe W, de Smedt S and de Cuyper M 2009 Stable long-term intracellular labelling with fluorescently tagged cationic magneticliposomes ChemBioChem 10 257-67
6. Berry C C and Curtis A S G 2003 Functionalisation of magnetic nanoparticles for applications in biomedicine J. Phys.D: Appl. Phys. 36 198-206
7. Neuberger T, Schopf B, Hofmann H, Hofmann M and von Rechenberg B 2005 Cuperparamagnetic nanoparticles for biomedical applications: possibilities and limitations for a new drug delivery system J. Magn. Magn. Mater. 293 483-96
8. Sun C, Lee J S H and Zhang M 2008 Magnetic nanoparticles in MR imaging and drug delivery Adv. Drug Del. Rev. 60 1252-65
9. Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T and Kindberg G M 2004 Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging Cell Tissue Res. 316 315-23
10. Chouly C, Pouliquen D, Lucet I, Jeune J-J and Pallet P 1996 Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution J. Microencapsulation 13 245-55
11. Debbage P and Jaschke W 2008 Molecular imaging with nanoparticles: giant roles for dwarf actors Histochem. Cell Biol. 130 845-75
12. Fujita T, Nishikawa M, Ohtsubo Y, Ohno J, Takakura Y, Sezaki H and Hashida H 1994 Control of in vivo fate of albumin derivatives utilizing combined chemical modification J. Drug Target. 2 157-65
13. Jain T K, Reddy M K, Morales M A, Leslie-Pelecky D L and Labhasetwar V 2008 Biodistribution, clearance and biocompatibility of iron oxide magnetic nanoparticles in rats Mol. Pharmceutics 5 316-27
14. Gaasch J A, Lochman P R, Geldenhuys W J, Allen D D and Van der Schfy C J 2007 Brain iron toxicity: differential responses of astrocytes, neurons and endothelial cells Neurochem. Res. 32 1196-208
15. Mehta S H, Webb R C, Ergul A, Tawak A and Dorrance A M 2004 Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 R283-R288
16. Minotti G 1943 Sources and role of iron in lipid peroxidation Chem. Res. Toxicol. 6 134-46
17. Maeda H 2001 The enhanced permeability and retention (EPT) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enz. Reg. 41 189-207
18. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H and Grune T 2004 Iron oxide particles for molecular resonance imaging cause transcient oxidative stress in rat macrophages Free Rad. Biol. Med. 36 976-84
19. Clement O, Siauve N, Lewin M, de Kerviler E, Cuenod C A and Frija G 1998 Contrast agents in magnetic resonance imaging of the liver: present and future Biomed. Pharmacoth. 52 51-8
20. Dobson J 2006 Magnetic nanoparticles for drug delivery Drug Dev. Res. 67 55-60
21. Lubbe A S, Alexiou C and Bergmann C 1999 Clinical applications of magnetic drug targeting J. Surg. Res. 95 200-06
22. Lubbe A S, Bergmann C, Brock J and McClure D G 2000 Physiological aspects in magnetic drug targeting J. Magn. Magn. Mater. 194 149-55
23. Grief A D and Richardson G 2005 Mathematical modelling of magnetically targeted drug delivery J. Magn. Magn. Mater. 293 455-63
24. Jain T K, Morales M A, Sahoo S K, Leslie-Pelecky D L and Labhasetwar V 2005 Iron oxide nanoparticles for sustained delivery of anticancer agents Mol. Pharmceutics 2 194-205
25. Kohler N, Sun C, Fichtenholz A, Gunn J, Fang C and Zhang M Q 2006 Methotrexate-immobilised poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery Small 2 785-92
26. Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y and Kobayashi T 2004 Magnetite nanoparticle-loaded anti-HER2 immuniliposomes for combination of antibody therapy with hyperthermia Cancer Lett. 212 167-75
27. McBain S C, Yiu H H and Dobson J 2008 Magnetic nanoparticles for gene and drug delivery Int. J. Nanomed. 3 169-80
28. Hirao K et al 2003 Targeted gene delivery to human osteocarcinoma cells with magnetic cationic liposomes under a magnetic field Int. J. Oncol. 22 1065-71
29. Haim H, Steiner I and Panet A 2005 Synchronised infection of cell cultures by magnetically controlled virus J. Virol. 79 622-5
30. Furlani E P and Ng K C 2008 Nanoscale magnetic biotransport with application to magnetofection Phys. Rev. 77 061914
31. Dobson J 2006 Gene therapy progress and prospectives: magnetic nanoparticle-based gene delivery Gene Ther. 13 283-7
32. Mykhaylyk O, Antequera Y S, Vlaskou D and Plank C 2007 Generation of magnetic nonviral gene transfer agents and magnetofecion in vitro Nat. Proto. 2 2391-411
33. Gazeau F, Levy M and Wilhelm C 2008 Optimizing magnetic nanoparticle design for nanothermotherapy Nanomedicine 3 831-44
34. c tuned nanoparticles of magnetic oxides for hyperthermia applications Biomed. Mater. Eng. 13 387-99
35. Masashige S 2002 Functional magnetic particles for medical application J. Biosci. Bioeng. 94 606-13
36. Fortin J P, Gaxeau G and Wilhelm C 2008 Intracellular heating of living cells through Neel relaxation of magnetic nanoparticles Eur. Biophys. J. 37 223-8
37. Jin H and Kang K A 2007 Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer Adv. Exp. Med. Biol. 599 45-52
38. Salloum M, Ma R H, Weeks D and Zhu L 2008 Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: experimental study in agarose gel Int. J. Hyperthermia 24 337-45 (Pubitemid 351911315)
39. Johannsen M et al 2007 Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution Eur. Urol. 52 1653-62 (Pubitemid 350052385)
40. Wust P et al 2006 Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures Int. J. Hyperthermia 22 673-85
41. Van Landeghem F K H, Maier-Hauff K, Jordan A, Hoffmann K T, Gneveckow R, Scholz R, Thiesen B, Bruck W and von Deimling A 2009 Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles Biomaterials 30 52-7
42. Kim D H, Kim K N, Kim K M and Lee Y K 2008 Targeting to carcinoma cells with chitosan and starch coated magnetic nanoparticles for magnetic hyperthermia J. Biomed. Mater. Res. A 88 1-11
43. 111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy Clin. Cancer Res. 11 7087-92
44. Naratajan A, Gruettner R, Ivkov G L, DeNardo G, Mirick A, Yuan A, Foreman A and DeNardo S J 2008 Nanoferrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics Bioconj. Chem. 19 1211-8
45. Walther W, Stein U and Schlag P 2002 Use of the human MRD1 promotor for heat-inducible expression of therapeutic genes Int. J. Cancer. 98 291-6
46. Ito A, Shinkai M, Honda H and Kobayashi T 2001 Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumour-targeted therapy Cancer Gene Ther. 8 649-54
47. Tang Q S, Zhang D S, Cong X M, Wan M L and Jin L Q 2008 Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression Biomaterials 29 2673-9
48. Enochs W S, Harsh F, Hochberg F and Weissledher R 1999 Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent J. Magn. Reson. Imaging 9 228-32
49. Varallyay P, Nesbit G, Muldoon L L, Nixon R R, Delashaw J I, Cohen J I, Petrillo A, Rink D and Neuwelt E A 2002 Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors AJNR Am. J. Neuroradiol. 23 510-9
50. Babincova M, Altanerova V, Altaner C, Cicmanex P and Babinec P 2004 In vivo heating of magnetic nanoparticles in an alternating magnetic field Med. Phys. 31 2219-21
51. Barry S E 2008 Challenges in the development of magnetic particles for therapeutic applications Int. J. Hyperthermia. 24 451-566
52. Cerdan S, Lotscher H R, Kunnecke B and Seeling J 1989 Monoclonal antibody-coated nagnetite particles as contrast agents in magnetic resonance imaging of tumors Mag. Reson. Med. 12 151-63
53. Bulte J W, Hoekstra Y, Kamman R L, Magin R L, Webb A G, Briggs R W, Go K G, Hulstart S and Miltenyi T H 1992 Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles Magn. Reson. Med. 25 148-57
54. Suzuki M, Honda H, Kobayashi T, wakabayashi T, Yoshida J and Takahashi M 1996 Development of a target directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic nanoparticles 13 127-32
55. Huh Y M 2006 In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals J. Am. Chem. Soc. 127 12387-91
56. Arternov D, Mori N, Okollie B and Bhujwalla A M 2003 MR imaging of the HER-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles Magn. Reson. Med. 49 403-8
57. Zhou Y, Drummond D C, Zou H, Hayes M E, Adams G P, Kirpotin D B and Marks J D 2007 Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells J. Mol. Biol. 371 934-47
58. Yang L et al 2009 Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging Small 2 235-43
59. Jun Y W, Huh Y M, Choi J S, Lee J H, Song H T, Kim S, Yoon S, Kim K S, Shin J S, Suh J S and Cheon J 2005 Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging J. Am. Chem. Soc. 127 5732-3
60. Lee J H, Huh Y M, Jun Y, Seo J, Jang J, Song H T, Kim S, Cho E J, Yoon H G, Suh J S and Cheon J 2007 Artificially engineered magnetic nanoparticles for ultra sensitive molecular imaging Nature Med. 13 95-9
61. McCArthy J R and Weissleder R 2008 Multifunctional magnetic nanoparticles for targeted imaging and therapy Adv. Drug Deliv. Rev. 60 1241-51
62. Lauret S, Forge D, Port M, Roch A, Robic C, Vander Elst L and Muller R N 2008 Magnetic iron oxide nanoparticles: synthesis, stabilisation, vectorisation, physiochemical chacterisations and biological applications Chem. Rev. 108 2064-10
63. Zhang Z, Mascheri N, Dharmakumar R, Fan Z, Paunesku T, Woloschak G and Li D 2009 Superparamagnetic iron oxide nanopartile-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging Cytotherapy 11 43-51
64. Yeh T C, Zhang W, Ildstad S T and Ho C 1993 Intracellular labelling of T-cells with superparamagnetic contrast agents Magn. Reson. Med. 30 617-25
65. Corot C, Robert P, Idee J M and Port M 2006 Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Deliv. Rev. 58 1471-504
66. Wilhelm C and Gazeau F 2008 Universal cell labelling with anionic magnetic nanoparticles 29 3161-74
67. Berry C C, de la Fuente J, Mullin M, Wai Ling Chu S and Curtis A 2007 Nuclear localisation of HIV-1 tat functionalised gold nanoparticles IEEE Trans. NanoBiosci. 6 262-9
68. Berry C C 2008 Intracellular delivery of nanoparticles via the HIV-1 tat peptide Nanomedicine 3 357-65
69. Josephson L, Tung C H, Moore A and Weissledher R 1999 High efficiency intracellular magnetic labelling with novel superparamagnetic-tat peptide conjugates Bioconj. Chem. 10 186-91
70. Lewin M, Carlesso N, Tung C H, Tnak X W, Cory D, Scadden D T and Weissledher R 2000 Tat peptide derivatised magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nature Biotechnol. 18 410-4
71. Dodd C H et al 2001 Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles J. Immunol. Methods 256 89-105
72. Zhao M, Kircher M F, Josephson L and Weissledher R 2002 Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake Bioconj. Chem. 13 840-4
73. Morgul M H, Raschzok N, Schwartlander R, Vondran F W, Michel R, Stelter L, Pinkernelle J, Jordan A, Teichgraber U and Sauer I M 2008 Tracking of primary human hepatocytes with clinical MRI: initial results with Tat-peptide modified superparamagnetic iron oxide particles Int. J. Artif. Organs 31 252-7
74. Guzman R et al 2007 Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI Proc. Natl Acad. Sci. USA 104 10211-6
75. Arai T, Kofidia T, Bulte J W, de Bruin J, Venook R D, Berry G J, McConnell M V, Quertermous T, Robbins R C and Yang P C 2006 Dual in vivo magnetic resonance evaluation of magnetically labelled mouse embryonic stem cells and cardiac function at 1.5 T Magn. Reson. Med. 55 203-9
76. Kraichman D L et al 2005 Dynamic imaging of allogenic mesenchymal stem cell trafficking to myocardial infarction Circulation 112 1451-61
77. Arbab A S, Pandit S D, Anderson S A, Yocum G T, Bur M, Frenkel V, Khuu H M, Read E J and Grank J A 2006 Magnetic resonance imaging and confocal microscopy studies on magnetically labelled endothelial progentitor cells trafficking to site of tumour angiogenesis Stem Cells 24 671-8
78. Hsiao J K, Tai M F, Chu H H, Chen S T, Lai D M, Hsieh S T, wang J L and Liu H M 2007 Magnetic nanoparticle labelling of mesenchymal stem cells without transfection agent: cellular behaviour and capability of detection with clinical 1.5 T magnetic resonance at the single cell level Magn. Reson. Med. 58 717-24
79. Ferreira L, Karp J M, Nobre L and Langer R 2008 New opportunities: the use of nanotechnologies to manipulate and track stem cells Cell Stem Cell 3 136-46
80. Helmus M N 2007 The need for rules and regulations Nature Nanotechnol. 2 333-4
81. Walczak P, Kedziorek D A, Gilad A A, Lin S and Bulte J W 2005 Instant MR labelling of stem cells using magnetoelectroporation Magn. Reson. Med. 54 1911-5
82. Mulder W J, Koole R, Brandwijk R J, Storm G, Chin P T, Strijkers G J, de Mello Doneg C, Nicolay K and Griffioen A W 2006 Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe Nano Lett. 6 1-6
83. Koole R et al 2008 Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging Bioconjug. Chem. 19 2471-9
84. Gaponik N, Radtchenko I L, Sukhorukov G B and Rogach A L 2004 Luminescent polymer microcapsules addressable by a magnetic field Langmuir 20 1449-52
85. Xie H Y, Zuo C, Lui Y, Zhang Z L, Pang D W, Li X L, Gong J P, Dickenson C and Zhou W 2005 Cell-targeting multifunctional nanospheres with both fluorescence and magnetism Small 5 506-9
86. 4-functionalised microtubules with magnetic fields Small 3 126-31
87. Block S M, Goldstein L S and Schnapp B J 1990 Bead movement by single kinesin molecules studied with optical tweezers Nature 348 358-2
88. Kuo S C and Sheetz M P 1993 Force of single kinesin molecules measured with optical tweezers Science 260 169-70
89. Jeney S, Florin E L and Horber J K 2001 Use of photonic force microscopy to study single-motor-molecule mechnics Methods Mol. Biol. 164 91-108
90. Mori T, Vale R D and Tomishige M 2007 How kinesin waits between steps Nature 450 750-4
91. Bachand M, Trent A M, Bunker B C and Bachand G D 2005 Physical factors affecting kinesin-based transport of synthetic nanoparticle cargo J. Nanosci. Nanotechnol. 5 718-22
92. Swiston A J, Cheng C, Um S H, Irvine D J, Cohen R E and Rubner M F 2008 Surface functionalization of living cells with multilayer patches Nano Lett. 8 4446-53
93. Dobson J 2008 Remote control of cellular behaviour with magnetic nanoparticles Nature Nanotechnol. 3 139-43